Stay updated with breaking news from Tananbaum Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synthetic biology company Evonetix which brings semiconductor technology to DNA synthesis, has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million (circa GB £44 million). Click to read more...
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale EVONETIX LTD ('Evonetix'), the synthetic biology company
Funding will enable development of DNA synthesis chip technology to commercial scale.